Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Adenoviridae Infections 1

Interventions

pembrolizumab 303 Carboplatin 232 Cisplatin 161 Paclitaxel 154 Gemcitabine 153 Pemetrexed 123 Bevacizumab 121 Docetaxel 106 durvalumab 83 Oxaliplatin 82 Nivolumab 82 Dexamethasone 80 atezolizumab 79 Fluorouracil 79 Cyclophosphamide 79 130-nm albumin-bound paclitaxel 74 Fulvestrant 72 Capecitabine 67 Injections 66 Cetuximab 64 Leucovorin 63 Rituximab 57 fludarabine 53 Lenalidomide 51 venetoclax 47 Prednisone 45 Letrozole 42 Irinotecan 42 enzalutamide 41 tislelizumab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Tumor Necrosis Factor-alpha × 90 days × Clear all

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡